TDC A/S
Presentation of DKT Holdings and TDC's Q3 2020 results
TDC will conduct a conference call for investors and analysts on November 6, 2020 at 14.30 CET to present the Q3 2020 results. Lasse Pilgaard, Chief Financial Officer, will comment on the results and answer questions during the conference call.
The investor and analyst conference will be available in Microsoft Teams at:
Dial in to Microsoft Teams is: +45 32 72 51 67 – Code: 353 019 709#
The conference call will refer to a slide deck that will be available from November 6, 2020 at approx. 10.00 CET on the link:
https://tdcgroup.com/en/investor-relations
Please mute your microphone before and during the presentation.
For inquiries regarding the above please contact TDC Investor Relations on +45 6663 7680 or investorrelations@tdc.dk.
TDC tickers
Reuters TDC.CO.
Bloomberg TDC DC.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Centessa Pharmaceuticals plc7.11.2025 14:00:00 CET | Press release
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Sanofi Winthrop Industrie7.11.2025 14:00:00 CET | Press release
Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review
PolTREG S.A.7.11.2025 14:00:00 CET | Press release
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies
SKAKO A/S7.11.2025 13:34:43 CET | Pressemeddelelse
Trading report Q3 2025 SKAKO A/S
Fast Ejendom Danmark7.11.2025 13:34:01 CET | Pressemeddelelse
Aktietilbagekøbsprogram
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
